gepirone has been researched along with Depression, Involutional in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, Y; Bhandari, R; Kaur Gill, A; Kaur, J; Kaur, S; Kuhad, A; Singh, R | 1 |
| Brown, CS; Derogatis, LR; Fabre, LF; Smith, LC | 1 |
| Clayton, AH; Derogatis, LR; Fabre, LF; Goldstein, I; Smith, LC | 1 |
| Janczewski, J; Janssens, CJ; Jokinen, R; Keller, MB; Ruwe, FJ; Sitsen, JM | 1 |
| Almási, J; Rihmer, Z | 1 |
| Davies, CA; Deliyannides, D; Klein, DF; McGrath, PJ; Quitkin, FM; Stewart, JW; Taylor, BP | 1 |
| Bielski, RJ; Cunningham, L; Horrigan, JP; Londborg, PD; Smith, WT; Weiss, K | 1 |
2 review(s) available for gepirone and Depression, Involutional
| Article | Year |
|---|---|
Gepirone hydrochloride: a novel antidepressant with 5-HT1A agonistic properties.
Topics: Antidepressive Agents; Depressive Disorder, Major; Humans; Pyrimidines; Randomized Controlled Trials as Topic; Serotonin 5-HT1 Receptor Agonists | 2019 |
[Review of antidepressants from the TCAs to the third generation drugs].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Combinations; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Piperazines; Pyrimidines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Trazodone; Triazoles; Venlafaxine Hydrochloride | 2004 |
4 trial(s) available for gepirone and Depression, Involutional
| Article | Year |
|---|---|
Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women.
Topics: Adolescent; Adult; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Libido; Middle Aged; Pyrimidines; Sexual Dysfunctions, Psychological; Treatment Outcome; Young Adult | 2011 |
Relapse prevention with gepirone ER in outpatients with major depression.
Topics: Adult; Antidepressive Agents; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Europe; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Pyrimidines; Secondary Prevention; Treatment Outcome | 2005 |
Remission rates with 3 consecutive antidepressant trials: effectiveness for depressed outpatients.
Topics: Adult; Ambulatory Care; Antidepressive Agents; Clinical Protocols; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Imipramine; Male; Patient Compliance; Placebos; Psychiatric Status Rating Scales; Pyrimidines; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2005 |
Gepirone extended-release in the treatment of adult outpatients with major depressive disorder: a double-blind, randomized, placebo-controlled, parallel-group study.
Topics: Adolescent; Adult; Ambulatory Care; Delayed-Action Preparations; Demography; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Pyrimidines; Serotonin Receptor Agonists; Severity of Illness Index; Surveys and Questionnaires | 2008 |
1 other study(ies) available for gepirone and Depression, Involutional
| Article | Year |
|---|---|
The effect of gepirone-ER in the treatment of sexual dysfunction in depressed men.
Topics: Adult; Antidepressive Agents; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Humans; Male; Middle Aged; Pyrimidines; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological | 2012 |